{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T12:54:51Z","timestamp":1788353691690,"version":"build-2803163510"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,11]],"date-time":"2025-08-11T00:00:00Z","timestamp":1754870400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,11]],"date-time":"2025-08-11T00:00:00Z","timestamp":1754870400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100021856","name":"Ministero dell'Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","award":["PE0000015, Concession Decree No. 1243 of 2 August 2022 adopted by the Italian Ministry of University and Research, CUP H33C22000680006, project title \u201cAgeing well in an ageing society\u2014A novel public-private alliance to generate socioeconomic, biomedical and technological solutions for an inclusive Italian ageing society\u2013 AGE-IT\u201d"],"award-info":[{"award-number":["PE0000015, Concession Decree No. 1243 of 2 August 2022 adopted by the Italian Ministry of University and Research, CUP H33C22000680006, project title \u201cAgeing well in an ageing society\u2014A novel public-private alliance to generate socioeconomic, biomedical and technological solutions for an inclusive Italian ageing society\u2013 AGE-IT\u201d"]}],"id":[{"id":"10.13039\/501100021856","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021856","name":"Ministero dell'Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","award":["D93C22000890001, project title \u201cON Foods\u2014Research and innovation network on food and nutrition Sustainability, Safety and Security\u2014Working ON Foods\u201d"],"award-info":[{"award-number":["D93C22000890001, project title \u201cON Foods\u2014Research and innovation network on food and nutrition Sustainability, Safety and Security\u2014Working ON Foods\u201d"]}],"id":[{"id":"10.13039\/501100021856","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020581","name":"Fondazione AIRC per la ricerca sul cancro ETS","doi-asserted-by":"publisher","award":["IG 2019 \u201cRegulation of lipid metabolic pathways in the gut liver axis: relevance in hepatocarcinoma\u201d Id 23239"],"award-info":[{"award-number":["IG 2019 \u201cRegulation of lipid metabolic pathways in the gut liver axis: relevance in hepatocarcinoma\u201d Id 23239"]}],"id":[{"id":"10.13039\/100020581","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","award":["PNRR M6C2\u2014Investimento 2.1 Valorizzazione e potenziamento della ricerca biomedica del SSN\u201d, project code PNRR-MR1-2022-12376395. CUP H93C22000780006, project title: Italian Autoimmune Liver Disease (IT-AILD) Clinical Research Network (CRN)"],"award-info":[{"award-number":["PNRR M6C2\u2014Investimento 2.1 Valorizzazione e potenziamento della ricerca biomedica del SSN\u201d, project code PNRR-MR1-2022-12376395. CUP H93C22000780006, project title: Italian Autoimmune Liver Disease (IT-AILD) Clinical Research Network (CRN)"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Diabetol"],"DOI":"10.1186\/s12933-025-02885-4","type":"journal-article","created":{"date-parts":[[2025,8,11]],"date-time":"2025-08-11T12:11:59Z","timestamp":1754914319000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Improving cardiovascular risk stratification: the role of abdominal obesity in predicting MACEs"],"prefix":"10.1186","volume":"24","author":[{"given":"Carlo","family":"De Matteis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Petruzzelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giusi","family":"Graziano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Novielli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ersilia","family":"Di Buduo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore","family":"Cantatore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elsa","family":"Berardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianfranco","family":"Antonica","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Arconzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marica","family":"Cariello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marilina","family":"Florio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucilla","family":"Crudele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Moschetta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,11]]},"reference":[{"issue":"2","key":"2885_CR1","doi-asserted-by":"publisher","first-page":"e014402","DOI":"10.1161\/JAHA.119.014402","volume":"9","author":"B Miao","year":"2020","unstructured":"Miao B, Hernandez AV, Alberts MJ, Mangiafico N, Roman YM, Coleman CI. Incidence and predictors of major adverse cardiovascular events in patients with established atherosclerotic disease or multiple risk factors. J Am Heart Assoc. 2020;9(2):e014402.","journal-title":"J Am Heart Assoc"},{"issue":"25","key":"2885_CR2","doi-asserted-by":"publisher","first-page":"1954","DOI":"10.1056\/NEJMoa013591","volume":"346","author":"Y Higashi","year":"2002","unstructured":"Higashi Y, Sasaki S, Nakagawa K, Matsuura H, Oshima T, Chayama K. Endothelial function and oxidative stress in renovascular hypertension. N Engl J Med. 2002;346(25):1954\u201362.","journal-title":"N Engl J Med"},{"issue":"20","key":"2885_CR3","doi-asserted-by":"publisher","first-page":"2442","DOI":"10.1097\/CM9.0000000000002839","volume":"136","author":"W Chen","year":"2023","unstructured":"Chen W, Li Z, Zhao Y, Chen Y, Huang R. Global and national burden of atherosclerosis from 1990 to 2019: trend analysis based on the Global Burden of Disease Study 2019. Chin Med J (Engl). 2023;136(20):2442\u201350.","journal-title":"Chin Med J (Engl)"},{"issue":"4","key":"2885_CR4","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1161\/CIRCRESAHA.115.307611","volume":"118","author":"W Herrington","year":"2016","unstructured":"Herrington W, Lacey B, Sherliker P, Armitage J, Lewington S. Epidemiology of atherosclerosis and the potential to reduce the global burden of atherothrombotic disease. Circ Res. 2016;118(4):535\u201346.","journal-title":"Circ Res"},{"issue":"16","key":"2885_CR5","doi-asserted-by":"publisher","first-page":"e029505","DOI":"10.1161\/JAHA.123.029505","volume":"12","author":"Q Kong","year":"2023","unstructured":"Kong Q, Ma X, Li L, Wang C, Du X, Wan Y. Atherosclerosis Burden of Brain- and Heart-Supplying Arteries and the Relationship With Vascular Risk in Patients With Ischemic Stroke. J Am Heart Assoc. 2023;12(16):e029505.","journal-title":"J Am Heart Assoc"},{"issue":"5","key":"2885_CR6","doi-asserted-by":"publisher","first-page":"e721","DOI":"10.1016\/S2214-109X(20)30117-0","volume":"8","author":"P Song","year":"2020","unstructured":"Song P, Fang Z, Wang H, Cai Y, Rahimi K, Zhu Y, et al. Global and regional prevalence, burden, and risk factors for carotid atherosclerosis: a systematic review, meta-analysis, and modelling study. Lancet Glob Health. 2020;8(5):e721\u20139.","journal-title":"Lancet Glob Health"},{"issue":"20","key":"2885_CR7","doi-asserted-by":"publisher","first-page":"2529","DOI":"10.1016\/j.jacc.2019.10.009","volume":"74","author":"GA Mensah","year":"2019","unstructured":"Mensah GA, Roth GA, Fuster V. The global burden of cardiovascular diseases and risk factors: 2020 and beyond. J Am Coll Cardiol. 2019;74(20):2529\u201332.","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"2885_CR8","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1177\/0003319717721603","volume":"69","author":"E Oikonomou","year":"2018","unstructured":"Oikonomou E, Psaltopoulou T, Georgiopoulos G, Siasos G, Kokkou E, Antonopoulos A, et al. Western dietary pattern is associated with severe coronary artery disease. Angiology. 2018;69(4):339\u201346.","journal-title":"Angiology"},{"issue":"11","key":"2885_CR9","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1016\/j.clinthera.2023.09.020","volume":"45","author":"L Nedkoff","year":"2023","unstructured":"Nedkoff L, Briffa T, Zemedikun D, Herrington S, Wright FL. Global trends in atherosclerotic cardiovascular disease. Clin Ther. 2023;45(11):1087\u201391.","journal-title":"Clin Ther"},{"key":"2885_CR10","unstructured":"Cardiovascular diseases (CVDs) [Internet]. [cited 2024 Oct 15]. Available from: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/cardiovascular-diseases-(cvds)"},{"issue":"25","key":"2885_CR11","doi-asserted-by":"publisher","first-page":"2361","DOI":"10.1016\/j.jacc.2022.11.005","volume":"80","author":"M Vaduganathan","year":"2022","unstructured":"Vaduganathan M, Mensah GA, Turco JV, Fuster V, Roth GA. The global burden of cardiovascular diseases and risk. J Am Coll Cardiol. 2022;80(25):2361\u201371.","journal-title":"J Am Coll Cardiol"},{"issue":"25","key":"2885_CR12","doi-asserted-by":"publisher","first-page":"2980","DOI":"10.1016\/j.jacc.2020.11.021","volume":"76","author":"GA Roth","year":"2020","unstructured":"Roth GA, Mensah GA, Fuster V. The global burden of cardiovascular diseases and risks: a compass for global action. J Am Coll Cardiol. 2020;76(25):2980\u20131.","journal-title":"J Am Coll Cardiol"},{"issue":"15","key":"2885_CR13","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1001\/jama.297.15.jpc70004","volume":"297","author":"JC Tardif","year":"2007","unstructured":"Tardif JC, Gr\u00e9goire J, L\u2019Allier PL, Ibrahim R, Lesp\u00e9rance J, Heinonen TM, et al. Effects of reconstituted high-density lipoprotein infusions on coronary atherosclerosis: a randomized controlled trial. JAMA. 2007;297(15):1675\u201382.","journal-title":"JAMA"},{"issue":"17","key":"2885_CR14","doi-asserted-by":"publisher","first-page":"2292","DOI":"10.1001\/jama.290.17.2292","volume":"290","author":"SE Nissen","year":"2003","unstructured":"Nissen SE, Tsunoda T, Tuzcu EM, Schoenhagen P, Cooper CJ, Yasin M, et al. Effect of recombinant ApoA-I milano on coronary atherosclerosis in patients with acute coronary syndromes: a randomized controlled trial. JAMA. 2003;290(17):2292\u2013300.","journal-title":"JAMA"},{"issue":"20","key":"2885_CR15","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1056\/NEJM198711123172001","volume":"17","author":"MH Frick","year":"1987","unstructured":"Frick MH, Elo O, Haapa K, Heinonen OP, Heinsalmi P, Helo P, et al. Helsinki heart study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease. N Engl J Med. 1987;17(20):1237\u201345.","journal-title":"N Engl J Med"},{"key":"2885_CR16","doi-asserted-by":"crossref","unstructured":"Kh Z, Es S. HDL infusion for the management of atherosclerosis: current developments and new directions. Current opinion in lipidology [Internet]. 2016 Dec [cited 2024 Oct 16];27(6). Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/27653220\/","DOI":"10.1097\/MOL.0000000000000349"},{"issue":"18","key":"2885_CR17","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1056\/NEJMoa1615664","volume":"376","author":"MS Sabatine","year":"2017","unstructured":"Sabatine MS, Giugliano RP, Keech AC, Honarpour N, Wiviott SD, Murphy SA, et al. Evolocumab and clinical outcomes in patients with cardiovascular disease. N Engl J Med. 2017;376(18):1713\u201322.","journal-title":"N Engl J Med"},{"issue":"25","key":"2885_CR18","doi-asserted-by":"publisher","first-page":"2387","DOI":"10.1056\/NEJMoa1410489","volume":"372","author":"CP Cannon","year":"2015","unstructured":"Cannon CP, Blazing MA, Giugliano RP, McCagg A, White JA, Theroux P, et al. Ezetimibe added to statin therapy after acute coronary syndromes. N Engl J Med. 2015;372(25):2387\u201397.","journal-title":"N Engl J Med"},{"issue":"12","key":"2885_CR19","doi-asserted-by":"publisher","first-page":"101342","DOI":"10.1016\/j.cpcardiol.2022.101342","volume":"47","author":"T Abdul-Rahman","year":"2022","unstructured":"Abdul-Rahman T, Bukhari SMA, Herrera EC, Awuah WA, Lawrence J, de Andrade H, et al. Lipid lowering therapy: an era beyond statins. Curr Probl Cardiol. 2022;47(12):101342.","journal-title":"Curr Probl Cardiol"},{"issue":"5","key":"2885_CR20","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.3390\/biomedicines10051090","volume":"10","author":"E Dayar","year":"2022","unstructured":"Dayar E, Pechanova O. Targeted Strategy in Lipid-Lowering Therapy. Biomedicines. 2022;10(5):1090.","journal-title":"Biomedicines"},{"issue":"9438","key":"2885_CR21","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1016\/S0140-6736(04)17018-9","volume":"364","author":"S Yusuf","year":"2004","unstructured":"Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet. 2004;364(9438):937\u201352.","journal-title":"Lancet"},{"issue":"38","key":"2885_CR22","doi-asserted-by":"publisher","first-page":"3912","DOI":"10.1093\/eurheartj\/ehae178","volume":"45","author":"JW McEvoy","year":"2024","unstructured":"McEvoy JW, McCarthy CP, Bruno RM, Brouwers S, Canavan MD, Ceconi C, et al. 2024 ESC Guidelines for the management of elevated blood pressure and hypertension. Eur Heart J. 2024;45(38):3912\u20134018.","journal-title":"Eur Heart J"},{"issue":"38","key":"2885_CR23","doi-asserted-by":"publisher","first-page":"3720","DOI":"10.1093\/eurheartj\/ehad191","volume":"44","author":"RA Byrne","year":"2023","unstructured":"Byrne RA, Rossello X, Coughlan JJ, Barbato E, Berry C, Chieffo A, et al. 2023 ESC Guidelines for the management of acute coronary syndromes. Eur Heart J. 2023;44(38):3720\u2013826.","journal-title":"Eur Heart J"},{"issue":"36","key":"2885_CR24","doi-asserted-by":"publisher","first-page":"3415","DOI":"10.1093\/eurheartj\/ehae177","volume":"45","author":"C Vrints","year":"2004","unstructured":"Vrints C, Andreotti F, Koskinas KC, Rossello X, Adamo M, Ainslie J, et al. 2024 ESC Guidelines for the management of chronic coronary syndromes. Eur Heart J. 2004;45(36):3415\u2013537.","journal-title":"Eur Heart J"},{"issue":"39","key":"2885_CR25","doi-asserted-by":"publisher","first-page":"4043","DOI":"10.1093\/eurheartj\/ehad192","volume":"44","author":"N Marx","year":"2023","unstructured":"Marx N, Federici M, Sch\u00fctt K, M\u00fcller-Wieland D, Ajjan RA, Antunes MJ, et al. 2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes. Eur Heart J. 2023;44(39):4043\u2013140.","journal-title":"Eur Heart J"},{"issue":"14","key":"2885_CR26","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1016\/j.jacc.2010.05.034","volume":"56","author":"S Mottillo","year":"2010","unstructured":"Mottillo S, Filion KB, Genest J, Joseph L, Pilote L, Poirier P, et al. The metabolic syndrome and cardiovascular risk a systematic review and meta-analysis. J Am Coll Cardiol. 2010;56(14):1113\u201332.","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"2885_CR27","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.amjhyper.2003.10.009","volume":"17","author":"AM Wilson","year":"2004","unstructured":"Wilson AM, O\u2019Neal D, Nelson CL, Prior DL, Best JD, Jenkins AJ. Comparison of arterial assessments in low and high vascular disease risk groups. Am J Hypertens. 2004;17(4):285\u201391.","journal-title":"Am J Hypertens"},{"issue":"22","key":"2885_CR28","doi-asserted-by":"publisher","first-page":"2673","DOI":"10.1161\/hc4601.099485","volume":"104","author":"T Heitzer","year":"2001","unstructured":"Heitzer T, Schlinzig T, Krohn K, Meinertz T, M\u00fcnzel T. Endothelial dysfunction, oxidative stress, and risk of cardiovascular events in patients with coronary artery disease. Circulation. 2001;104(22):2673\u20138.","journal-title":"Circulation"},{"issue":"21","key":"2885_CR29","doi-asserted-by":"publisher","first-page":"e984","DOI":"10.1161\/CIR.0000000000000973","volume":"143","author":"TM Powell-Wiley","year":"2021","unstructured":"Powell-Wiley TM, Poirier P, Burke LE, Despr\u00e9s JP, Gordon-Larsen P, Lavie CJ, et al. Obesity and cardiovascular disease: a scientific statement from the American heart association. Circulation. 2021;143(21):e984-1010.","journal-title":"Circulation"},{"issue":"3","key":"2885_CR30","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1056\/NEJMra1514009","volume":"376","author":"SB Heymsfield","year":"2017","unstructured":"Heymsfield SB, Wadden TA. Mechanisms, pathophysiology, and management of obesity. N Engl J Med. 2017;376(3):254\u201366.","journal-title":"N Engl J Med"},{"issue":"7","key":"2885_CR31","doi-asserted-by":"publisher","first-page":"3094","DOI":"10.3390\/molecules28073094","volume":"28","author":"A Artasensi","year":"2023","unstructured":"Artasensi A, Mazzolari A, Pedretti A, Vistoli G, Fumagalli L. Obesity and type 2 diabetes: adiposopathy as a triggering factor and therapeutic options. Molecules. 2023;28(7):3094.","journal-title":"Molecules"},{"issue":"8","key":"2885_CR32","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1056\/NEJMra2032804","volume":"386","author":"AM Cypess","year":"2022","unstructured":"Cypess AM. Reassessing human adipose tissue. N Engl J Med. 2022;386(8):768\u201379.","journal-title":"N Engl J Med"},{"issue":"1","key":"2885_CR33","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1111\/apha.12646","volume":"219","author":"PM Vanhoutte","year":"2017","unstructured":"Vanhoutte PM, Shimokawa H, Feletou M, Tang EHC. Endothelial dysfunction and vascular disease - a 30th anniversary update. Acta Physiol (Oxf). 2017;219(1):22\u201396.","journal-title":"Acta Physiol (Oxf)"},{"issue":"8828","key":"2885_CR34","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1016\/0140-6736(92)93147-F","volume":"340","author":"DS Celermajer","year":"1992","unstructured":"Celermajer DS, Sorensen KE, Gooch VM, Spiegelhalter DJ, Miller OI, Sullivan ID, et al. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. The Lancet. 1992;340(8828):1111\u20135.","journal-title":"The Lancet"},{"issue":"10","key":"2885_CR35","doi-asserted-by":"publisher","first-page":"1840","DOI":"10.1161\/ATVBAHA.117.308848","volume":"37","author":"S Tavakoli","year":"2017","unstructured":"Tavakoli S, Downs K, Short JD, Nguyen HN, Lai Y, Jerabek PA, et al. Characterization of macrophage polarization states using combined measurement of 2-deoxyglucose and glutamine accumulation. Arterioscler Thromb Vasc Biol. 2017;37(10):1840\u20138.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"1","key":"2885_CR36","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1093\/cvr\/cvaa085","volume":"117","author":"Y Alexander","year":"2021","unstructured":"Alexander Y, Osto E, Schmidt-Trucks\u00e4ss A, Shechter M, Trifunovic D, Duncker DJ, et al. Endothelial function in cardiovascular medicine: a consensus paper of the European society of cardiology working groups on atherosclerosis and vascular biology, aorta and peripheral vascular diseases, coronary pathophysiology and microcirculation, and thrombosis. Cardiovasc Res. 2021;117(1):29\u201342.","journal-title":"Cardiovasc Res"},{"key":"2885_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanepe.2023.100774","volume":"36","author":"MK Hansen","year":"2024","unstructured":"Hansen MK, Mortensen MB, Warnakula Olesen KK, Thrane PG, Maeng M. Non-HDL cholesterol and residual risk of cardiovascular events in patients with ischemic heart disease and well-controlled LDL cholesterol: a cohort study. Lancet Reg Health Eur. 2024;36: 100774.","journal-title":"Lancet Reg Health Eur"},{"issue":"6","key":"2885_CR38","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1056\/NEJM197602052940601","volume":"294","author":"GG Rhoads","year":"1976","unstructured":"Rhoads GG, Gulbrandsen CL, Kagan A. Serum lipoproteins and coronary heart disease in a population study of Hawaii Japanese men. N Engl J Med. 1976;294(6):293\u20138.","journal-title":"N Engl J Med"},{"issue":"9738","key":"2885_CR39","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/S0140-6736(10)60713-1","volume":"376","author":"PM Ridker","year":"2010","unstructured":"Ridker PM, Genest J, Boekholdt SM, Libby P, Gotto AM, Nordestgaard BG, et al. HDL cholesterol and residual risk of first cardiovascular events after treatment with potent statin therapy: an analysis from the JUPITER trial. Lancet. 2010;376(9738):333\u20139.","journal-title":"Lancet"},{"key":"2885_CR40","first-page":"109","volume":"15","author":"G Assmann","year":"2004","unstructured":"Assmann G, Gotto AM. HDL cholesterol and protective factors in atherosclerosis. Circulation. 2004;15:109.","journal-title":"Circulation"},{"issue":"25","key":"2885_CR41","doi-asserted-by":"publisher","first-page":"2383","DOI":"10.1056\/NEJMoa1409065","volume":"371","author":"A Rohatgi","year":"2014","unstructured":"Rohatgi A, Khera A, Berry JD, Givens EG, Ayers CR, Wedin KE, et al. HDL cholesterol efflux capacity and incident cardiovascular events. N Engl J Med. 2014;371(25):2383\u201393.","journal-title":"N Engl J Med"},{"issue":"9943","key":"2885_CR42","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1016\/S0140-6736(14)61217-4","volume":"384","author":"DJ Rader","year":"2014","unstructured":"Rader DJ, Hovingh GK. HDL and cardiovascular disease. Lancet. 2014;384(9943):618\u201325.","journal-title":"Lancet"},{"issue":"5","key":"2885_CR43","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1002\/wsbm.137","volume":"3","author":"M Vacca","year":"2011","unstructured":"Vacca M, Degirolamo C, Mariani-Costantini R, Palasciano G, Moschetta A. Lipid-sensing nuclear receptors in the pathophysiology and treatment of the metabolic syndrome. Wiley Interdiscip Rev Syst Biol Med. 2011;3(5):562\u201387.","journal-title":"Wiley Interdiscip Rev Syst Biol Med"},{"key":"2885_CR44","unstructured":"Units of measurement in the EU| EUR-Lex [Internet]. [cited 2024 Mar 7]. Available from: https:\/\/eur-lex.europa.eu\/EN\/legal-content\/summary\/units-of-measurement-in-the-eu.html"},{"key":"2885_CR45","unstructured":"9. Pharmacologic Approaches to Glycemic Treatment: Standards of Care in Diabetes-2024. Diabetes care [Internet]. 2024 Jan 1 [cited 2024 Oct 16];47(Suppl 1). Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/38078590\/"},{"key":"2885_CR46","unstructured":"WHO. World Health Organization, Definition of Smoking. [cited 2025 June 4]; Available from: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/tobacco"},{"issue":"25","key":"2885_CR47","doi-asserted-by":"publisher","first-page":"2439","DOI":"10.1093\/eurheartj\/ehab309","volume":"42","author":"SCORE2 working group and ESC Cardiovascular risk collaboration","year":"2021","unstructured":"SCORE2 working group and ESC Cardiovascular risk collaboration. SCORE2 risk prediction algorithms: new models to estimate 10-year risk of cardiovascular disease in Europe. Eur Heart J. 2021;42(25):2439\u201354.","journal-title":"Eur Heart J"},{"issue":"25","key":"2885_CR48","doi-asserted-by":"publisher","first-page":"2455","DOI":"10.1093\/eurheartj\/ehab312","volume":"42","author":"SCORE2-OP working group and ESC Cardiovascular risk collaboration","year":"2021","unstructured":"SCORE2-OP working group and ESC Cardiovascular risk collaboration. SCORE2-OP risk prediction algorithms: estimating incident cardiovascular event risk in older persons in four geographical risk regions. Eur Heart J. 2021;42(25):2455\u201367.","journal-title":"Eur Heart J"},{"issue":"6","key":"2885_CR49","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1161\/CIRCULATIONAHA.107.699579","volume":"117","author":"RB D\u2019Agostino","year":"2008","unstructured":"D\u2019Agostino RB, Vasan RS, Pencina MJ, Wolf PA, Cobain M, Massaro JM, et al. General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation. 2008;117(6):743\u201353.","journal-title":"Circulation"},{"issue":"10","key":"2885_CR50","first-page":"567","volume":"25","author":"J Genest","year":"2009","unstructured":"Genest J, McPherson R, Frohlich J, Anderson T, Campbell N, Carpentier A, et al. 2009 Canadian Cardiovascular Society\/Canadian guidelines for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease in the adult - 2009 recommendations. Can J Cardiol. 2009;25(10):567\u201379.","journal-title":"Can J Cardiol"},{"issue":"3","key":"2885_CR51","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1038\/s41574-019-0310-7","volume":"16","author":"R Ross","year":"2020","unstructured":"Ross R, Neeland IJ, Yamashita S, Shai I, Seidell J, Magni P, et al. Waist circumference as a vital sign in clinical practice: a consensus statement from the IAS and ICCR working group on visceral obesity. Nat Rev Endocrinol. 2020;16(3):177\u201389.","journal-title":"Nat Rev Endocrinol"},{"issue":"9771","key":"2885_CR52","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1016\/S0140-6736(11)60105-0","volume":"377","author":"D Wormser","year":"2011","unstructured":"Wormser D, Kaptoge S, Di Angelantonio E, Wood AM, Pennells L, et al. Separate and combined associations of body-mass index and abdominal adiposity with cardiovascular disease: collaborative analysis of 58 prospective studies. Lancet. 2011;377(9771):1085\u201395.","journal-title":"Lancet"},{"issue":"20","key":"2885_CR53","doi-asserted-by":"publisher","first-page":"2105","DOI":"10.1056\/NEJMoa0801891","volume":"359","author":"T Pischon","year":"2008","unstructured":"Pischon T, Boeing H, Hoffmann K, Bergmann M, Schulze MB, Overvad K, et al. General and abdominal adiposity and risk of death in Europe. N Engl J Med. 2008;359(20):2105\u201320.","journal-title":"N Engl J Med"},{"issue":"1","key":"2885_CR54","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-94277-3","volume":"11","author":"C De Matteis","year":"2021","unstructured":"De Matteis C, Cariello M, Graziano G, Battaglia S, Suppressa P, Piazzolla G, et al. AST to platelet ratio index (APRI) is an easy-to-use predictor score for cardiovascular risk in metabolic subjects. Sci Rep. 2021;11(1): 14834.","journal-title":"Sci Rep"},{"issue":"38","key":"2885_CR55","doi-asserted-by":"publisher","first-page":"4063","DOI":"10.1093\/eurheartj\/ehae508","volume":"45","author":"KC Koskinas","year":"2024","unstructured":"Koskinas KC, Van Craenenbroeck EM, Antoniades C, Bl\u00fcher M, Gorter TM, Hanssen H, et al. Obesity and cardiovascular disease: an ESC clinical consensus statement. Eur Heart J. 2024;45(38):4063\u201398.","journal-title":"Eur Heart J"},{"issue":"11","key":"2885_CR56","first-page":"e563","volume":"140","author":"DK Arnett","year":"2019","unstructured":"Arnett DK, Blumenthal RS, Albert MA, Buroker AB, Goldberger ZD, Hahn EJ, et al. ACC\/AHA guideline on the primary prevention of cardiovascular disease: executive summary: a report of the american college of cardiology\/american heart association task force on clinical practice guidelines. Circulation. 2019;140(11):e563\u201395.","journal-title":"Circulation"},{"issue":"8","key":"2885_CR57","doi-asserted-by":"publisher","first-page":"1910","DOI":"10.3390\/nu15081910","volume":"15","author":"C De Matteis","year":"2023","unstructured":"De Matteis C, Crudele L, Battaglia S, Loconte T, Rotondo A, Ferrulli R, et al. Identification of a novel score for adherence to the Mediterranean diet that is inversely associated with visceral adiposity and cardiovascular risk: the Chrono Med Diet Score (CMDS). Nutrients. 2023;15(8):1910.","journal-title":"Nutrients"},{"issue":"2","key":"2885_CR58","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.cmet.2010.07.002","volume":"12","author":"G Lo Sasso","year":"2010","unstructured":"Lo Sasso G, Murzilli S, Salvatore L, D\u2019Errico I, Petruzzelli M, Conca P, et al. Intestinal specific LXR activation stimulates reverse cholesterol transport and protects from atherosclerosis. Cell Metab. 2010;12(2):187\u201393.","journal-title":"Cell Metab"},{"issue":"16","key":"2885_CR59","doi-asserted-by":"publisher","first-page":"1978","DOI":"10.1161\/hc3901.096667","volume":"104","author":"BJ O\u2019Connell","year":"2001","unstructured":"O\u2019Connell BJ, Genest J. High-density lipoproteins and endothelial function. Circulation. 2001;104(16):1978\u201383.","journal-title":"Circulation"},{"issue":"2","key":"2885_CR60","doi-asserted-by":"publisher","first-page":"290","DOI":"10.5009\/gnl210084","volume":"16","author":"Y Kim","year":"2022","unstructured":"Kim Y, Han E, Lee JS, Lee HW, Kim BK, Kim MK, et al. Cardiovascular risk is elevated in lean subjects with nonalcoholic fatty liver disease. Gut Liver. 2022;16(2):290\u20139.","journal-title":"Gut Liver"},{"issue":"2","key":"2885_CR61","doi-asserted-by":"publisher","first-page":"159087","DOI":"10.1016\/j.bbalip.2021.159087","volume":"1867","author":"J H\u00e4rdfeldt","year":"2022","unstructured":"H\u00e4rdfeldt J, Cariello M, Simonelli S, Ossoli A, Scialpi N, Piglionica M, et al. Abdominal obesity negatively influences key metrics of reverse cholesterol transport. Biochimica et Biophysica Acta (BBA). 2022;1867(2):159087.","journal-title":"Biochimica et Biophysica Acta (BBA)"},{"issue":"2","key":"2885_CR62","doi-asserted-by":"publisher","first-page":"e002087","DOI":"10.1136\/openhrt-2022-002087","volume":"9","author":"O Csenteri","year":"2022","unstructured":"Csenteri O, Jancs\u00f3 Z, Sz\u00f6ll\u00f6si GJ, Andr\u00e9ka P, Vajer P. Differences of cardiovascular risk assessment in clinical practice using SCORE and SCORE2. Open Heart. 2022;9(2):e002087.","journal-title":"Open Heart"},{"issue":"6B","key":"2885_CR63","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1079\/PHN2002394","volume":"5","author":"E Riboli","year":"2002","unstructured":"Riboli E, Hunt KJ, Slimani N, Ferrari P, Norat T, Fahey M, et al. European prospective investigation into cancer and nutrition (EPIC): study populations and data collection. Public Health Nutr. 2002;5(6B):1113\u201324.","journal-title":"Public Health Nutr"}],"container-title":["Cardiovascular Diabetology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-025-02885-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12933-025-02885-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-025-02885-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T00:19:34Z","timestamp":1757377174000},"score":1,"resource":{"primary":{"URL":"https:\/\/cardiab.biomedcentral.com\/articles\/10.1186\/s12933-025-02885-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,11]]},"references-count":63,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2885"],"URL":"https:\/\/doi.org\/10.1186\/s12933-025-02885-4","relation":{},"ISSN":["1475-2840"],"issn-type":[{"value":"1475-2840","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,11]]},"assertion":[{"value":"12 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Committee (Interdisciplinary Department of Medicine; n. 311, MSC\/PBMC\/2015, approved on 12 January 2015) of the Azienda Ospedaliero-Universitaria Policlinico di Bari (Bari, Italy) in accordance with the requirements of the Declaration of Helsinki. In accordance with the approved Ethics Committee, only patients who were already 18\u00a0years old or older were included. Informed consent was obtained from all subjects involved in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"328"}}